Highlights from ESMO 2020: Lung Cancer
Featuring Dr. Barbara Melosky, Dr. Parneet Cheema, and Dr. Peter Ellis. Trials Discussed: Presidential Symposiums: CROWN, ADAURA, and Lung Art Metastatic NSCLC: ZENITH20 and TAK-788 Metastatic NSCLC a EGFR Drug Conjugates: Amivantamab a Lazertinib and Patritumab Deruxtecan Stage III NSCLC: 4-year survival of PACIFIC trial Neoadjuvant Trials: durvalumab in NSCLC and PRINCEPS trial This podcast has been made available through sponsorship from Amgen.
